Abstract | BACKGROUND: METHODS: Thirty-three patients with HNSCC were treated with porfimer sodium-mediated PDT followed by intraoperative light activation at 630 nm via fiber optic microlens delivered after 48 hours of injection. RESULTS: The complete response (CR) rate was 72.7%, while the efficacy (CR + partial response) rate was 97.0%. The rate of good local control (i.e., CR without recurrence after PDT) achieved after the initial PDT (82.6%) was significantly higher than that achieved after the second or third PDT (10%); this rate remained at 62.1% without functional disturbance and disfigurement even after excluding four previously untreated patients. The final local control rate following PDT plus additional therapies was 73.8%. CONCLUSIONS:
PDT is an effective therapy to treat HNSCC, and leads to an improved quality of life in patients with residual or recurrent disease. Lasers Surg. Med. 50:420-426, 2018. © 2018 Wiley Periodicals, Inc.
|
Authors | Seiji Hosokawa, Satoru Takebayashi, Goro Takahashi, Jun Okamura, Hiroyuki Mineta |
Journal | Lasers in surgery and medicine
(Lasers Surg Med)
Vol. 50
Issue 5
Pg. 420-426
(07 2018)
ISSN: 1096-9101 [Electronic] United States |
PMID | 29399863
(Publication Type: Journal Article)
|
Copyright | © 2018 Wiley Periodicals, Inc. |
Chemical References |
- Photosensitizing Agents
- Dihematoporphyrin Ether
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Dihematoporphyrin Ether
(therapeutic use)
- Female
- Humans
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(drug therapy, mortality, pathology)
- Neoplasm, Residual
- Photochemotherapy
- Photosensitizing Agents
(therapeutic use)
- Retrospective Studies
- Squamous Cell Carcinoma of Head and Neck
(drug therapy, mortality, pathology)
- Survival Rate
- Treatment Outcome
|